Sapience Therapeutics Presents ST101 Clinical Data and ST316

Sapience Therapeutics Presents ST101 Clinical Data and ST316 Preclinical Data at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Sapience Therapeutics Presents ST101 Clinical Data and ST316 Preclinical Data at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Juniper Point , Massachusetts , United States , Boston , Barry Kappel , Amy Conrad , International Conference On Molecular , Immunostimulatory Properties , Sapience Therapeutics Inc , Prnewswire Sapience Therapeutics Inc , European Commission , Molecular Targets , Cancer Therapeutics , Presentation Details , Biological Activity , Peptide Antagonist , Recurrent Glioblastoma , Results From , Multi Cohort Phase , Poster Session , Exhibit Hall , Aberrant Wnt Pathway , Fast Track , Stabilized Peptides Engineered Against Regulation , Sapience Therapeutics , Chief Executive , Investor Contact ,